Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

$ 8.00

5 (520) In stock

Molecular stratification within triple-negative breast cancer subtypes

Triple-negative breast cancer: understanding Wnt signaling in drug resistance, Cancer Cell International

Triple negative breast tumors contain heterogeneous cancer cells expressing distinct KRAS-dependent collective and disseminative invasion programs

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial

Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer

PDF) Triple-negative breast cancer: understanding Wnt signaling in drug resistance

Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial

IJMS, Free Full-Text

A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

Novel Therapies for Metastatic Triple-Negative Breast Cancer

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression